Friday, July 7, 2023

Cipla recalls six batches of bronchospasm treatment inhalation aerosol in US

Cipla recalls six batches of bronchospasm treatment inhalation aerosol in US The company#39;s wholly-owned subsidiary, Cipla USA Inc, is voluntarily recalling the six batches of Albuterol Sulfate inhalation Aerosol 90 mcg, manufactured in November 2021, to the consumer level, Cipla Ltd said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/eqf9Qu3
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

LTIMindtree Q4 Preview: Lower pass-through revenue seen impacting growth marginally

A compilation of estimates suggests the company#39;s Q4 FY24 net profit is projected to decline by 2.2 percent quarter on quarter to Rs 1,1...